8-K//Current report
Enliven Therapeutics, Inc. 8-K
Accession 0001193125-25-315196
$ELVNCIK 0001672619operating
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 9:11 AM ET
Size
405.5 KB
Accession
0001193125-25-315196
Documents
- 8-Kd937094d8k.htmPrimary
8-K
- EX-10.1d937094dex101.htm
EX-10.1
- EX-10.2d937094dex102.htm
EX-10.2
- EX-10.3d937094dex103.htm
EX-10.3
- EX-99.1d937094dex991.htm
EX-99.1
- EX-101.SCHelvn-20251209.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABelvn-20251209_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREelvn-20251209_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg937094g1211025922373.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-315196-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd937094d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001672619
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 9:11 AM ET
- Size
- 405.5 KB